Last week, Verus International ($VRUS) the leading quality foods company produced in the United States has acquired controlling interest in ZC Top Apparel Manufacturing, Inc., a Philippines-based maker of reusable N95 fabric masks and biohazard suits.
Investors may be surprised to see us enter this business, but we have international trade experience that is highly sought after in this current environment. We were approached early in the COVID-19 crisis by the management team at ZC Top, who were experiencing an overwhelming number of requests for protective gear from governments and other entities around the world.
Anshu Bhatnagar, Verus International CEO
The new ZC Top subsidiary currently has request for quotes (RFQs) from the U.S. Government and other governments, agencies and sellers on multiple continents. The Philippines-based facility has a peak production capacity of ten million masks per month. Based on pending orders, the Company believes that it can operate at near capacity for the foreseeable future.
Verus will provide additional details on this new subsidiary during the upcoming Fiscal 2019 financial results conference call on Monday, April 13, 2020 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
Should you Invest in Verus International ($VRUS)?
If you’re an investor with a high risk tolerance with pink sheet stocks then this company is something you should definitely look at.
Verus International ($VRUS) Financials
Verus International ($VRUS) skyrocketed to the green zone last week, turning into a positive trend and surging by +17%. With this latest performance, VRUS shares surged by +75% in over the last four-week period, additionally plunging -12% over the last 6 months.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VRUS stock in for the last two-week period is set at 50.02, with the RSI for the last single day of trading hit 64.32, and the three-weeks RSI is set at 49.91 for Verus International, ($VRUS). The present Moving Average for the last 50 days of trading for this stock 0.014, while it was recorded at 0.1200 for the last single week of trading, and 0.019 for the last 200 days.
Insight into Verus International
Operating Margin for any stock indicates how profitable investing would be, and Verus International ($VRUS) shares currently have an operating margin of -16.91%. Verus International’s Net Margin is presently recorded at -7%.
Return on Total Capital for VRUS is now -40.78%, given the latest momentum, and Return on Invested Capital for the company is -31.60. Return on Equity for this stock increased to 0, with Return on Assets sitting at -48.76. When it comes to the capital structure of this company has a Total Debt to Total Equity ratio set at 1,010.31. Additionally, VRUS Total Debt to Total Capital is recorded at 82.59, with Total Debt to Total Assets ending up at 64.89. Long-Term Debt to Equity for the company is recorded at 2,991.52, with the Long-Term Debt to Total Capital now at 76.87.
Reflecting on the efficiency of the workforce at the company, Verus International VRUS managed to generate an average of -$11,000,000 in revenue. Receivables Turnover for the company is 29.47 with a Total Asset Turnover recorded at a value of 0.50. VRUS’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.96 and a Current Ratio set at 0.77.
Verus International Insider Details
There are presently $0, or 0% of VRUS stock, in the hands of institutional investors. There are no institutional holders at this time of writing.
Positions in iBio Inc. stocks held by institutional investors remained the same at the end of February and at the time of the February reporting period, where 0 institutional holders increased their position in VRUS. Verus International by around 0 shares. The mentioned changes placed institutional holdings at 0 shares, according to the latest SEC report filing. VRUS stock had 0 new institutional investments in for a total of 0 shares.
